CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.19
-0.16 (-2.18%)
At close: Jul 29, 2026, 4:00 PM EDT
7.46
+0.27 (3.76%)
Pre-market: Jul 30, 2026, 5:43 AM EDT
CorMedix Market Cap
CorMedix has a market cap or net worth of $564.07 million as of July 30, 2026. Its market cap has decreased by -30.58% in one year.
Market Cap
564.07M
Enterprise Value
533.40M
1-Year Change
-30.58%
Ranking
Category
Stock Price
$7.19
ChartMarket Cap Chart
Since May 13, 2010, CorMedix's market cap has increased from $34.20M to $564.07M, an increase of 1,549.32%. That is a compound annual growth rate of 18.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 564.07M | -38.44% |
| Dec 31, 2025 | 916.30M | 86.43% |
| Dec 31, 2024 | 491.50M | 138.48% |
| Dec 29, 2023 | 206.10M | 18.31% |
| Dec 30, 2022 | 174.20M | 0.52% |
| Dec 31, 2021 | 173.30M | -27.40% |
| Dec 31, 2020 | 238.70M | 27.78% |
| Dec 31, 2019 | 186.80M | 37.45% |
| Dec 31, 2018 | 135.90M | 304.46% |
| Dec 29, 2017 | 33.60M | -45.72% |
| Dec 30, 2016 | 61.90M | -13.79% |
| Dec 31, 2015 | 71.80M | 67.76% |
| Dec 31, 2014 | 42.80M | 114.00% |
| Dec 31, 2013 | 20.00M | 143.90% |
| Dec 31, 2012 | 8.20M | 156.25% |
| Dec 30, 2011 | 3.20M | -84.62% |
| Dec 31, 2010 | 20.80M | -39.18% |
| May 13, 2010 | 34.20M | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| REGENXBIO | 597.90M |
| Immix Biopharma | 590.88M |
| Zevra Therapeutics | 577.55M |
| Altimmune | 574.67M |
| ARS Pharmaceuticals | 569.01M |
| Relmada Therapeutics | 560.64M |
| Prime Medicine | 554.50M |
| Tectonic Therapeutic | 550.79M |